| 000 | 01111 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515171342.0 | ||
| 264 | 0 | _c20090713 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1471-0528 | ||
| 024 | 7 |
_a10.1111/j.1471-0528.2009.02130.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSingh, K | |
| 245 | 0 | 0 |
_aA statement for extensive primary cytoreductive surgery in advanced ovarian cancer. _h[electronic resource] |
| 260 |
_bBJOG : an international journal of obstetrics and gynaecology _cMay 2009 |
||
| 300 |
_a865; author reply 865-6 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xtherapy |
| 700 | 1 | _aBalega, J | |
| 700 | 1 | _aChan, K K | |
| 773 | 0 |
_tBJOG : an international journal of obstetrics and gynaecology _gvol. 116 _gno. 6 _gp. 865; author reply 865-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1471-0528.2009.02130.x _zAvailable from publisher's website |
| 999 |
_c18860531 _d18860531 |
||